Mohamed Abdelaziz, National Oncology Committee Member at the Ministry of Health and Population of Egypt, shared a post on LinkedIn:
“Optimizing Health Economy in Hematology and Oncology – A Collaborative Discussion for Egypt’s Future.
I recently had the pleasure of participating in two different scientific sessions on optimizing health economy in hematology and oncology, bringing together oncologists and key stakeholders from across Egypt’s healthcare landscape – including representatives from governmental, private, and pharmaceutical sectors.
The discussion was truly fruitful and interactive, focusing on how we can ensure sustainable access to innovative therapies while maintaining value-driven, patient-centered care.
Topics ranged from treatment optimization and cost-effectiveness to real-world evidence and the importance of cross-sector collaboration in shaping Egypt’s oncology ecosystem.
I’m grateful for the opportunity to exchange insights with such dedicated professionals and look forward to continuing this dialogue toward smarter, more equitable health solutions for our patients.
Thanks, EVA pharma, for organizing two successful days.”
More posts featuring Mohamed Abdelaziz.
